Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 791

1.

Atrial Fibrillation/Flutter Hospitalizations among U.S. Medicaid Recipients with and without Systemic Lupus Erythematosus.

Chen SK, Barbhaiya M, Solomon DH, Guan H, Yoshida K, Feldman CH, Everett BM, Costenbader KH.

J Rheumatol. 2019 Nov 1. pii: jrheum.190502. doi: 10.3899/jrheum.190502. [Epub ahead of print]

PMID:
31676703
2.

Acute Calcium Pyrophosphate Crystal Arthritis Flare Rate and Risk Factors for Recurrence.

Yates KA, Yoshida K, Xu C, Lyu H, Norvang V, Solomon DH, Tedeschi SK.

J Rheumatol. 2019 Nov 1. pii: jrheum.190778. doi: 10.3899/jrheum.190778. [Epub ahead of print]

PMID:
31676701
3.

Reply to Letter to the Editor: "Comparison of Teriparatide and Denosumab in Patients Switching from Long-Term Bisphosphonate Use".

Lyu H, Zhao SS, Solomon DH.

J Clin Endocrinol Metab. 2019 Oct 25. pii: dgz123. doi: 10.1210/clinem/dgz123. [Epub ahead of print] No abstract available.

PMID:
31650171
4.

A prospective study of dual-energy CT scanning, US and X-ray in acute calcium pyrophosphate crystal arthritis.

Tedeschi SK, Solomon DH, Yoshida K, Vanni K, Suh DH, Smith SE.

Rheumatology (Oxford). 2019 Oct 19. pii: kez431. doi: 10.1093/rheumatology/kez431. [Epub ahead of print] No abstract available.

PMID:
31630175
5.

Quality improvement for rheumatoid arthritis care: results from a focus group.

Forman M, Leatherwood C, Iversen MD, Solomon DH, Desai SP.

Clin Exp Rheumatol. 2019 Sep 13. [Epub ahead of print]

PMID:
31573471
6.

Fool Me Twice? The Reemergence of Rofecoxib and the Orphan Drug Act.

Lee TT, Solomon DH, Kesselheim AS.

Ann Intern Med. 2019 Oct 1. doi: 10.7326/M19-1218. [Epub ahead of print] No abstract available.

PMID:
31569216
7.

Incorporating natural language processing to improve classification of axial spondyloarthritis using electronic health records.

Zhao SS, Hong C, Cai T, Xu C, Huang J, Ermann J, Goodson NJ, Solomon DH, Cai T, Liao KP.

Rheumatology (Oxford). 2019 Sep 19. pii: kez375. doi: 10.1093/rheumatology/kez375. [Epub ahead of print]

PMID:
31535693
8.

Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trials.

Vanni KMM, Lyu H, Solomon DH.

Rheumatology (Oxford). 2019 Aug 23. pii: kez343. doi: 10.1093/rheumatology/kez343. [Epub ahead of print]

PMID:
31504937
9.

Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus.

Li D, Yoshida K, Feldman CH, Speyer C, Barbhaiya M, Guan H, Solomon DH, Everett BM, Costenbader KH.

Rheumatology (Oxford). 2019 Sep 3. pii: kez433. doi: 10.1093/rheumatology/kez433. [Epub ahead of print] No abstract available.

PMID:
31504932
10.

Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis.

Sung YK, Yoshida K, Prince FHM, Frits ML, Cho SK, Choe JY, Lee HS, Lee J, Lee SS, Yoo DH, Helfgott SM, Shadick NA, Weinblatt ME, Solomon DH, Bae SC.

PLoS One. 2019 Aug 14;14(8):e0221314. doi: 10.1371/journal.pone.0221314. eCollection 2019.

11.

Association of Preoperative Opioid Use With Mortality and Short-term Safety Outcomes After Total Knee Replacement.

Kim SC, Jin Y, Lee YC, Lii J, Franklin PD, Solomon DH, Franklin JM, Katz JN, Desai RJ.

JAMA Netw Open. 2019 Jul 3;2(7):e198061. doi: 10.1001/jamanetworkopen.2019.8061.

12.

Smoking status and cause-specific discontinuation of tumour necrosis factor inhibitors in axial spondyloarthritis.

Zhao SS, Yoshida K, Jones GT, Hughes DM, Duffield SJ, Tedeschi SK, Lyu H, Moots RJ, Solomon DH, Goodson NJ.

Arthritis Res Ther. 2019 Jul 22;21(1):177. doi: 10.1186/s13075-019-1958-z.

13.

Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus.

Li D, Yoshida K, Feldman CH, Speyer C, Barbhaiya M, Guan H, Solomon DH, Everett BM, Costenbader KH.

Rheumatology (Oxford). 2019 Jul 18. pii: kez288. doi: 10.1093/rheumatology/kez288. [Epub ahead of print]

PMID:
31321417
14.

Correction to: Association between inflammation and systolic blood pressure in RA compared to patients without RA.

Yu Z, Kim SC, Vanni K, Huang J, Desai R, Murphy SN, Solomon DH, Liao KP.

Arthritis Res Ther. 2019 Jul 8;21(1):170. doi: 10.1186/s13075-019-1940-9.

15.

Comparison of Teriparatide and Denosumab in Patients Switching From Long-Term Bisphosphonate Use.

Lyu H, Zhao SS, Yoshida K, Tedeschi SK, Xu C, Nigwekar SU, Leder BZ, Solomon DH.

J Clin Endocrinol Metab. 2019 Nov 1;104(11):5611-5620. doi: 10.1210/jc.2019-00924.

PMID:
31265071
16.

Blood pressure lowering medication initiation and fracture risk: a SWAN pharmacoepidemiology study.

Solomon DH, Ruppert K, Kazlauskaite R, Finkelstein JS, Habel LA.

Arch Osteoporos. 2019 Jun 28;14(1):73. doi: 10.1007/s11657-019-0618-x.

PMID:
31254147
17.

Patterns of prescription opioid use before total hip and knee replacement among US Medicare enrollees.

Jin Y, Solomon DH, Franklin PD, Lee YC, Lii J, Katz JN, Kim SC.

Osteoarthritis Cartilage. 2019 Oct;27(10):1445-1453. doi: 10.1016/j.joca.2019.05.023. Epub 2019 Jun 26.

PMID:
31251985
18.

Comorbidity burden in axial spondyloarthritis: a cluster analysis.

Zhao SS, Radner H, Siebert S, Duffield SJ, Thong D, Hughes DM, Moots RJ, Solomon DH, Goodson NJ.

Rheumatology (Oxford). 2019 Oct 1;58(10):1746-1754. doi: 10.1093/rheumatology/kez119.

PMID:
31220322
19.

Low Dose Methotrexate and Mucocutaneous Adverse Events: Results of a Systematic Literature Review and Meta-Analysis of Randomized Controlled Trials.

Lalani R, Lyu H, Vanni K, Solomon DH.

Arthritis Care Res (Hoboken). 2019 May 31. doi: 10.1002/acr.23999. [Epub ahead of print]

PMID:
31150157
20.

The contribution of obesity to prescription opioid use in the United States.

Stokes A, Berry KM, Collins JM, Hsiao CW, Waggoner JR, Johnston SS, Ammann EM, Scamuffa RF, Lee S, Lundberg DJ, Solomon DH, Felson DT, Neogi T, Manson JE.

Pain. 2019 Oct;160(10):2255-2262. doi: 10.1097/j.pain.0000000000001612.

21.

A tool for empirical equipoise assessment in multigroup comparative effectiveness research.

Yoshida K, Solomon DH, Haneuse S, Kim SC, Patorno E, Tedeschi SK, Lyu H, Hernández-Díaz S, Glynn RJ.

Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):934-941. doi: 10.1002/pds.4767. Epub 2019 May 27.

PMID:
31131965
22.

Comparison of comorbidities and treatment between ankylosing spondylitis and non-radiographic axial spondyloarthritis in the United States.

Zhao SS, Ermann J, Xu C, Lyu H, Tedeschi SK, Liao KP, Yoshida K, Moots RJ, Goodson NJ, Solomon DH.

Rheumatology (Oxford). 2019 Nov 1;58(11):2025-2030. doi: 10.1093/rheumatology/kez171.

PMID:
31081033
23.

Prevalence and predictors for sustained remission in rheumatoid arthritis.

Sung YK, Yoshida K, Prince FHM, Frits ML, Cho SK, Choe JY, Lee HS, Lee J, Lee SS, Yoo DH, Helfgott SM, Shadick NA, Weinblatt ME, Solomon DH, Bae SC.

PLoS One. 2019 Apr 19;14(4):e0214981. doi: 10.1371/journal.pone.0214981. eCollection 2019. Erratum in: PLoS One. 2019 Aug 14;14(8):e0221314.

24.

Lipids and Cardiovascular Risk Through the Lens of Rheumatoid Arthritis.

Liao KP, Solomon DH.

Arthritis Rheumatol. 2019 Sep;71(9):1393-1395. doi: 10.1002/art.40891. Epub 2019 Jul 22. No abstract available.

PMID:
30983150
25.

Temporal increases in 25-hydroxyvitamin D in midlife women: Longitudinal results from the Study of Women's Health Across the Nation.

Mitchell DM, Ruppert K, Udupa N, Bassir F, Darakananda K, Solomon DH, Lian Y, Cauley JA, Karlamangla AS, Greendale GA, Finkelstein JS, Burnett-Bowie SM.

Clin Endocrinol (Oxf). 2019 Jul;91(1):48-57. doi: 10.1111/cen.13986. Epub 2019 Apr 24.

PMID:
30972777
26.

Risk of malignancy associated with use of tocilizumab versus other biologics in patients with rheumatoid arthritis: A multi-database cohort study.

Kim SC, Pawar A, Desai RJ, Solomon DH, Gale S, Bao M, Sarsour K, Schneeweiss S.

Semin Arthritis Rheum. 2019 Oct;49(2):222-228. doi: 10.1016/j.semarthrit.2019.03.002. Epub 2019 Mar 9.

PMID:
30967248
27.

Asymptomatic hyperuricemia and coronary flow reserve in patients with metabolic syndrome.

Kim SC, Di Carli MF, Garg RK, Vanni K, Wang P, Wohlfahrt A, Yu Z, Lu F, Campos A, Bibbo CF, Smith S, Solomon DH.

BMC Rheumatol. 2018 Jun 20;2:17. doi: 10.1186/s41927-018-0027-6. eCollection 2018.

28.

Trust in Publication: Now More Than Ever.

Bucala RJ, Solomon DH.

Arthritis Rheumatol. 2019 Oct;71(10):1593-1594. doi: 10.1002/art.40882. Epub 2019 Aug 4. No abstract available.

PMID:
30860662
29.

A Stress Buffering Perspective on the Progression of Alpha-1 Antitrypsin Deficiency.

Tian X, Solomon DH, Smith RA.

Health Commun. 2019 Mar 7:1-9. doi: 10.1080/10410236.2019.1584782. [Epub ahead of print]

PMID:
30843437
30.

Derivation and Validation of a Major Toxicity Risk Score Among Nonsteroidal Antiinflammatory Drug Users Based on Data From a Randomized Controlled Trial.

Solomon DH, Shao M, Wolski K, Nissen S, Husni ME, Paynter N.

Arthritis Rheumatol. 2019 Aug;71(8):1225-1231. doi: 10.1002/art.40870. Epub 2019 Jun 12.

PMID:
30801994
31.

The impact of smoking on response to TNF inhibitors in axial spondyloarthritis: methodological considerations for longitudinal observational studies.

Zhao S, Yoshida K, Jones GT, Hughes DM, Tedeschi SK, Lyu H, Moots RJ, Solomon DH, Goodson NJ.

Arthritis Care Res (Hoboken). 2019 Feb 14. doi: 10.1002/acr.23851. [Epub ahead of print]

PMID:
30762311
32.

Relational Turbulence and Marital Communication When Children with Autism Start School: A Longitudinal Dyadic Diary Study.

Brisini KSC, Solomon DH.

Health Commun. 2019 Feb 1:1-11. doi: 10.1080/10410236.2019.1567445. [Epub ahead of print]

PMID:
30706722
33.

Association of Geography and Access to Health Care Providers With Long-Term Prescription Opioid Use in Medicare Patients With Severe Osteoarthritis: A Cohort Study.

Desai RJ, Jin Y, Franklin PD, Lee YC, Bateman BT, Lii J, Solomon DH, Katz JN, Kim SC.

Arthritis Rheumatol. 2019 May;71(5):712-721. doi: 10.1002/art.40834. Epub 2019 Apr 2.

PMID:
30688044
34.

Intervals between bone mineral density testing with dual-energy X-ray absorptiometry scans in clinical practice.

Lyu H, Yoshida K, Tedeschi SK, Zhao S, Xu C, Nigwekar SU, Leder BZ, Solomon DH.

Osteoporos Int. 2019 Apr;30(4):923-927. doi: 10.1007/s00198-019-04847-5. Epub 2019 Jan 24.

PMID:
30680429
35.

Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study.

Pawar A, Desai RJ, Solomon DH, Santiago Ortiz AJ, Gale S, Bao M, Sarsour K, Schneeweiss S, Kim SC.

Ann Rheum Dis. 2019 Apr;78(4):456-464. doi: 10.1136/annrheumdis-2018-214367. Epub 2019 Jan 24.

PMID:
30679153
36.

Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis.

Lillegraven S, Greenberg JD, Reed GW, Saunders K, Curtis JR, Harrold L, Hochberg MC, Pappas DA, Kremer JM, Solomon DH.

PLoS One. 2019 Jan 23;14(1):e0210459. doi: 10.1371/journal.pone.0210459. eCollection 2019.

37.

Predictors of Achieving Remission among Patients with Psoriatic Arthritis Initiating a Tumor Necrosis Factor Inhibitor.

Ogdie A, Palmer JL, Greenberg J, Curtis JR, Harrold LR, Solomon DH, Kavanaugh A, Kremer JM, Mease PJ.

J Rheumatol. 2019 May;46(5):475-482. doi: 10.3899/jrheum.171034. Epub 2019 Jan 15.

PMID:
30647182
38.

Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validation.

Ljung L, Ueda P, Liao KP, Greenberg JD, Etzel CJ, Solomon DH, Askling J.

RMD Open. 2018 Dec 16;4(2):e000771. doi: 10.1136/rmdopen-2018-000771. eCollection 2018.

39.

Comparison of Denosumab and Bisphosphonates in Patients With Osteoporosis: A Meta-Analysis of Randomized Controlled Trials.

Lyu H, Jundi B, Xu C, Tedeschi SK, Yoshida K, Zhao S, Nigwekar SU, Leder BZ, Solomon DH.

J Clin Endocrinol Metab. 2019 May 1;104(5):1753-1765. doi: 10.1210/jc.2018-02236.

PMID:
30535289
40.

Multinomial Extension of Propensity Score Trimming Methods: A Simulation Study.

Yoshida K, Solomon DH, Haneuse S, Kim SC, Patorno E, Tedeschi SK, Lyu H, Franklin JM, Stürmer T, Hernández-Díaz S, Glynn RJ.

Am J Epidemiol. 2019 Mar 1;188(3):609-616. doi: 10.1093/aje/kwy263.

PMID:
30517602
41.

Chronic Opioid Use in Rheumatoid Arthritis: Prevalence and Predictors.

Lee YC, Kremer J, Guan H, Greenberg J, Solomon DH.

Arthritis Rheumatol. 2019 May;71(5):670-677. doi: 10.1002/art.40789. Epub 2019 Mar 6.

PMID:
30474933
42.

Grief and Post-traumatic Growth Following Miscarriage: The Role of Meaning Reconstruction and Partner Supportive Communication.

Tian X, Solomon DH.

Death Stud. 2018 Nov 19:1-11. doi: 10.1080/07481187.2018.1539051. [Epub ahead of print]

PMID:
30451589
43.

Challenges in Implementing Treat-to-Target Strategies in Rheumatology.

Ford JA, Solomon DH.

Rheum Dis Clin North Am. 2019 Feb;45(1):101-112. doi: 10.1016/j.rdc.2018.09.007. Review.

PMID:
30447739
44.

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.

Ridker PM, Everett BM, Pradhan A, MacFadyen JG, Solomon DH, Zaharris E, Mam V, Hasan A, Rosenberg Y, Iturriaga E, Gupta M, Tsigoulis M, Verma S, Clearfield M, Libby P, Goldhaber SZ, Seagle R, Ofori C, Saklayen M, Butman S, Singh N, Le May M, Bertrand O, Johnston J, Paynter NP, Glynn RJ; CIRT Investigators.

N Engl J Med. 2019 Feb 21;380(8):752-762. doi: 10.1056/NEJMoa1809798. Epub 2018 Nov 10.

45.

Azathioprine and Mycophenolate Mofetil Adherence Patterns and Predictors Among Medicaid Beneficiaries With Systemic Lupus Erythematosus.

Feldman CH, Collins J, Zhang Z, Xu C, Subramanian SV, Kawachi I, Solomon DH, Costenbader KH.

Arthritis Care Res (Hoboken). 2019 Nov;71(11):1419-1424. doi: 10.1002/acr.23792.

PMID:
30354025
46.

Relationship of Interleukin-1β Blockade With Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled Trial.

Solomon DH, Glynn RJ, MacFadyen JG, Libby P, Thuren T, Everett BM, Ridker PM.

Ann Intern Med. 2018 Oct 16;169(8):535-542. doi: 10.7326/M18-1167. Epub 2018 Sep 18.

PMID:
30242335
47.

Adverse Events and Resource Use Before and After Treat-to-Target in Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial.

Solomon DH, Yu Z, Katz JN, Bitton A, Corrigan C, Fraenkel L, Harrold LR, Smolen JS, Losina E, Lu B.

Arthritis Care Res (Hoboken). 2019 Sep;71(9):1243-1248. doi: 10.1002/acr.23755. Epub 2019 Jul 19.

PMID:
30221841
48.

Racial/ethnic variation in stroke rates and risks among patients with systemic lupus erythematosus.

Barbhaiya M, Feldman CH, Guan H, Chen SK, Fischer MA, Solomon DH, Everett BM, Costenbader KH.

Semin Arthritis Rheum. 2019 Apr;48(5):840-846. doi: 10.1016/j.semarthrit.2018.07.012. Epub 2018 Jul 31.

PMID:
30205982
49.

Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical Trial.

Choudhry NK, Isaac T, Lauffenburger JC, Gopalakrishnan C, Lee M, Vachon A, Iliadis TL, Hollands W, Elman S, Kraft JM, Naseem S, Doheny S, Lee J, Barberio J, Patel L, Khan NF, Gagne JJ, Jackevicius CA, Fischer MA, Solomon DH, Sequist TD.

JAMA Intern Med. 2018 Sep 1;178(9):1182-1189. doi: 10.1001/jamainternmed.2018.3189.

50.

Area-Level Predictors of Medication Nonadherence Among US Medicaid Beneficiaries With Lupus: A Multilevel Study.

Feldman CH, Costenbader KH, Solomon DH, Subramanian SV, Kawachi I.

Arthritis Care Res (Hoboken). 2019 Jul;71(7):903-913. doi: 10.1002/acr.23721.

PMID:
30055088

Supplemental Content

Loading ...
Support Center